Max Healthcare Institute has announced a series of significant decisions following its board meeting held on May 21, 2026. Key outcomes include the approval of a final dividend, the re-appointment of auditors, and plans for new hospital construction.
The board approved a final dividend of ₹2 per equity share, representing 20% of the face value of ₹10 each, for the financial year 2025-26. This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM) and will be paid within 30 days of the meeting’s conclusion.
In addition to the dividend, the board has approved the re-appointment of M/s. Chandra Wadhwa & Co. as the cost auditors for the financial year 2026-27. This decision follows the recommendation of the Audit Committee.
The board also approved the re-classification of Radiant Life Care Hospital Foundation from the ‘Promoter Group’ to the ‘Public’ category, pending approval from the relevant stock exchanges. This move aligns with regulatory requirements under SEBI Listing Regulations.
A significant development is the board’s approval for the construction of Phase-I of Max Super Specialty Hospital in Lucknow. The hospital will be built on a 5-acre land parcel owned by the company at Shaheed Path, with a capacity to accommodate approximately 712 beds.
Furthermore, the board has decided to shift the company’s registered office from Mumbai, Maharashtra to Gurugram, Haryana, subject to necessary approvals.
The board has also re-appointed Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for a three-year term starting October 1, 2026. This re-appointment is contingent upon approval at the forthcoming AGM.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).